PDF(Pubmed)
Abstract：
UNASSIGNED: Hypertension is a major source of morbidity and mortality worldwide, particularly for racial and ethnic minorities who face higher rates of hypertension and worse health-related outcomes. Recent research has reported on protective associations between classic psychedelics and hypertension; however, there is a need to explore how race and ethnicity may moderate such associations.
UNASSIGNED: We used data from the National Survey on Drug Use and Health (2005-2014) to assess whether race and ethnicity moderate the associations between classic psychedelic use - specifically psilocybin - and past year hypertension.
UNASSIGNED: Hispanic identity moderated the associations between psilocybin use and past year hypertension. Furthermore, individuals who used psilocybin and identified as Non-Hispanic White had reduced odds of hypertension (aOR: 0.83); however, these associations were not observed for any other racial or ethnic groups in our study for individuals who used psilocybin.
UNASSIGNED: Overall, our results demonstrate that the associations between psychedelics and hypertension may vary by race and ethnicity. Longitudinal studies and clinical trials can further advance this research and determine whether such differences exist in causal contexts.
UNASSIGNED: https://osf.io/xsz2p/?view_only=0bf7b56749034c18abb2a3f8d3d4bc0b.
UNASSIGNED: We used data from the National Survey on Drug Use and Health (2005-2014) to assess whether race and ethnicity moderate the associations between classic psychedelic use - specifically psilocybin - and past year hypertension.
UNASSIGNED: Hispanic identity moderated the associations between psilocybin use and past year hypertension. Furthermore, individuals who used psilocybin and identified as Non-Hispanic White had reduced odds of hypertension (aOR: 0.83); however, these associations were not observed for any other racial or ethnic groups in our study for individuals who used psilocybin.
UNASSIGNED: Overall, our results demonstrate that the associations between psychedelics and hypertension may vary by race and ethnicity. Longitudinal studies and clinical trials can further advance this research and determine whether such differences exist in causal contexts.
UNASSIGNED: https://osf.io/xsz2p/?view_only=0bf7b56749034c18abb2a3f8d3d4bc0b.
摘要：
■高血压是全球发病率和死亡率的主要来源，特别是对于高血压发病率较高和健康相关结局较差的种族和少数民族。最近的研究报道了经典迷幻药与高血压之间的保护性关联；然而，有必要探索种族和族裔如何调节这种联系。
■我们使用了全国药物使用与健康调查（2005-2014）的数据来评估种族和种族是否缓和了经典迷幻药使用-特别是psilocybin-与过去一年的高血压之间的关联。
■西班牙裔身份调节了裸盖菇素使用与过去一年的高血压之间的关联。此外，使用psilocybin并被确定为非西班牙裔白人的个体降低了高血压的几率（aOR：0.83）;然而，在我们的研究中,对于使用psilocybin的个体,未观察到任何其他种族或族裔群体的这些关联.
■总的来说，我们的结果表明,迷幻药和高血压之间的关联可能因种族和民族而异.纵向研究和临床试验可以进一步推进这项研究，并确定因果关系中是否存在这种差异。
■https://osf.io/xsz2p/?view_only=0bf7b56749034c18abb2a3f8d3d4bc0b。
■我们使用了全国药物使用与健康调查（2005-2014）的数据来评估种族和种族是否缓和了经典迷幻药使用-特别是psilocybin-与过去一年的高血压之间的关联。
■西班牙裔身份调节了裸盖菇素使用与过去一年的高血压之间的关联。此外，使用psilocybin并被确定为非西班牙裔白人的个体降低了高血压的几率（aOR：0.83）;然而，在我们的研究中,对于使用psilocybin的个体,未观察到任何其他种族或族裔群体的这些关联.
■总的来说，我们的结果表明,迷幻药和高血压之间的关联可能因种族和民族而异.纵向研究和临床试验可以进一步推进这项研究，并确定因果关系中是否存在这种差异。
■https://osf.io/xsz2p/?view_only=0bf7b56749034c18abb2a3f8d3d4bc0b。
